Refoxy Pharmaceuticals aims to discover and develop novel modulators of a central stress response pathway strongly associated with longevity to address a plethora of aging-related diseases. Target proteins were FOXO transcription factors which regulate the expression of multiple genes involved in processes like stress-resistance, metabolism, autophagy, cell cycle control, and longevity.